Funding and Investment
Require funding or expansion capital? Seeking attractive investment opportunities in this sector?
Aquapreneur is the place to meet potential partners, collaborators and experts who can assist you to succeed.
Have a patented technology or IP you want to monetize? Looking for complimentary technology or in-licensing?
- By Aquapreneur on February 16, 2015
How can we make the transition from a conventional ocean economy to a new blue economy? Join us at the third World Ocean Summit in Portugal as we explore the opportunity that blue growth presents for business and the ocean community, and identify practical solutions to the tension between economic development and environmental sustainability. World Ocean Summit http://www.economist.com/events-conferences/asia/world-ocean-summit will convene more than 250 global leaders from
In a bid to reduce waste from the harvest and export of southern rock lobsters – a multimillion dollar industry in South Australia – Flinders University and the South Australian Research and Development Institute (SARDI) have teamed up to find innovative ways of using leftover shells and parts from the processing of this premium seafood. The two institutes are working
MDPI is pleased to announce the publication of the following issue of Marine Drugs: Mar. Drugs, Volume 13, Issue 1 (January 2015), Pages 1-696 Table of Contents Special Issue Marine Anti-infective Agents Article: Marine-Derived Quorum-Sensing Inhibitory Activities Enhance the Antibacterial Efficacy of Tobramycin against Pseudomonas aeruginosa by Alessandro Busetti, George Shaw, Julianne Megaw, Sean P. Gorman, Christine A. Maggs and Brendan F. Gilmore Mar. Drugs 2015, 13(1),
A major international review of a peptide originally found in fish that could be used in the battle against cardiovascular disease has been published. Professor David Lambert from the University of Leicester’s Department of Cardiovascular Sciences contributed to the review, which has been largely written by the International Union of Basic and Clinical Pharmacology (IUPHAR) subcommittee, to pull together the
International Sustainability Group, Inc. announced the formation of a wholly owned subsidiary, ISG Health to commercialize natural health products. ISG Health is developing a complete line of algae-based nutraceutical products. These products are designed to support health through a formulation of nature’s minerals, proteins, antioxidants, vitamins and omegas for the health and wellness market. It is well known that these natural ingredients help with